AI-generated summary
The authors describe a retrospective case series of 10 outpatients with superficial facial vascular lesions treated with a 532-nm laser, with outcomes judged from paired photographs and a patient-reported global improvement scale. They report apparent improvement in most cases, with mild transient erythema or edema in 6 of 10 and no persistent adverse events. The study is uncontrolled, non-consecutive and hypothesis-generating, and the authors state it is not intended to establish efficacy.
- Participants
- 10
- Who or what was studied
- 10 outpatients with Fitzpatrick phototypes I-III and superficial facial vascular lesions such as telangiectasia and persistent erythema
- Wavelengths
- 532 nm
- Limits stated in the abstract
- Small, retrospective, single-arm, uncontrolled, non-consecutive case series that the authors state cannot establish efficacy and requires prospective confirmation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.